Drug profile · INN
difelikefalin
KORSUVA
difelikefalin (KORSUVA) is a kappa opioid receptor agonist. Associated with Seqirus (Australia) Pty Ltd.
EMA: approved TGA: approved Various (V03) V03AX
Patents linked 0
Pipeline programs 1
News articles 0
Drug details — difelikefalin
- Class
- Various (V03)
- Route
- —
- Patents
- 0
- Programs
- 1
- Data quality
- 0.83
Quick answer
difelikefalin (KORSUVA) is a kappa opioid receptor agonist. Associated with Seqirus (Australia) Pty Ltd.
Key facts
INN difelikefalin
Brand KORSUVA
Mechanism Kappa opioid receptor agonist
Target Kappa-type opioid receptor
Therapeutic class Various (V03)
ATC code V03AX
Originator Seqirus (Australia) Pty Ltd
Mechanism of action
Kappa opioid receptor agonist
Primary target: Kappa-type opioid receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | approved | — |
| TGA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is difelikefalin?
difelikefalin (KORSUVA) is a kappa opioid receptor agonist. Associated with Seqirus (Australia) Pty Ltd.
What is the brand name for difelikefalin?
KORSUVA is a marketed brand name for difelikefalin. Check FDA Drugs@FDA for the current US label holder and prescribing information.